MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HR-16-0011547
Jagbir Pharmaceuticals Private Limited
Jagbir Pharmaceuticals Private Limited - pharma in Rohtak, Haryana, India. Directors, charges & compliance details.
Revenue · FY 2023
₹1.46 Cr
▲ 221% YoY
Net profit · FY 2023
₹1.6 Lakh
Net margin 1.1%
EBITDA · FY 2023
₹2.49 Lakh
EBITDA margin 1.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Jagbir Pharmaceuticals Private Limited
Data last updated:
Jagbir Pharmaceuticals Private Limited is a private limited company based in Rohtak, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2017PTC069918. Its GSTIN is 06AAECJ0285F1ZS (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vidyasagar and Ravi Malik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Sh. Vidya Sagar, Kharawar Rohtak, Haryana, India – 124021.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.46 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.6 Lakh (net margin 1.1%) and EBITDA of ₹2.49 Lakh (EBITDA margin 1.7%).
Jagbir Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-16-0011547). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304HR2017PTC069918
Registration Number 069918
Incorporation Date 14 July 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-16-0011547
Recognitions & Rankings of Jagbir Pharmaceuticals
Contact details
Jagbir Pharmaceuticals Private Limited's registered office is in Rohtak, Haryana.
- Registered AddressC/O Sh. Vidya Sagar, Kharawar Rohtak, Haryana, India – 124021
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Jagbir Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Jagbir Pharmaceuticals Private Limited
FY 2023 filings availableJagbir Pharmaceuticals Private Limited reported revenue of ₹1.46 Cr (up 221% YoY) for FY 2023.
Revenue · FY 2023
₹1.46 Cr ▲ 221%
Net profit · FY 2023
₹1.6 Lakh margin 1.1%
EBITDA · FY 2023
₹2.49 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 221%
EBITDA CAGR growth
1 year
▲ 45%
5 years · compounded
▲ 74%
Revenue rose 221% in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jagbir Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jagbir Pharmaceuticals Private Limited
Jagbir Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vidyasagar | Director | 14 Jul 2017 | 9 Years 3 Months | Current |
| Ravi Malik | Director | 31 Mar 2025 | 1 Years 7 Months | Current |
| Ankit Sharma Also directs: Sylvexia Therapeutics LLP | Director | 28 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Jagbir Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ramsey Pharma Pvt Ltd | ₹1.47 Cr (FY 2025) | 14.0% | Kolkata, West Bengal, India | |||
| Strimed Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| 5G Care Pharma Private Limited | ₹1.47 Cr (FY 2025) | 273.0% | Coimbatore, Tamil Nadu, India | |||
| Sthree Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | -69.0% | Chennai, Tamil Nadu, India | |||
| KMRS Pharma Private Limited | ₹1.46 Cr (FY 2025) | 82.0% | Ahmedabad, Gujarat, India | |||
| Jagbir Pharmaceuticals Private Limitedthis company | ₹1.46 Cr (FY 2023) | ₹1.6 Lakh | 1.1% | 221.0% | Rohtak, Haryana, India | |
| Stevia Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2025) | -8.0% | Secunderabad, Telangana, India | |||
| Helisinki Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | 14.0% | Karnal, Haryana, India | |||
| Azeudus Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2022) | 128.0% | Bangalore, Karnataka, India | |||
| Primco Private Limited | ₹1.46 Cr (FY 2025) | -11.0% | Patna, Bihar, India | |||
| Trulay Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | -23.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Jagbir Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jagbir Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jagbir Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jagbir Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECJ0285F1ZS | Haryana | Active | 07 Oct 2017 |
To see the full GST registrations and return filing status of Jagbir Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jagbir Pharmaceuticals Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Ankit Sharma was appointed as Director on 28 Jan 2026.
Appointed
Ankit Sharma was appointed as Director.
AGM
Jagbir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Himanshu Gupta ceased to be Director.
Appointed
Ravi Malik was appointed as Director.
Filing
Jagbir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Ceased
Jagbir Malik Singh ceased to be Director.
Appointed
Vidyasagar was appointed as Director.
Incorporation
14 Jul 2017
Jagbir Pharmaceuticals Private Limited was registered on 14 Jul 2017 with Roc Delhi & aged 9 years 3 months as per MCA records.
Frequently asked questions
Jagbir Pharmaceuticals is an active private limited company based in Rohtak, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 July 2017 (9+ years old) and is registered under CIN U24304HR2017PTC069918.
Jagbir Pharmaceuticals has 3 current directors:
- Vidyasagar - Director
- Ravi Malik - Director
- Ankit Sharma - Director
The latest financial statements of Jagbir Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Jagbir Pharmaceuticals is 06AAECJ0285F1ZS, registered in Haryana.
The CIN (Corporate Identification Number) of Jagbir Pharmaceuticals is U24304HR2017PTC069918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jagbir Pharmaceuticals was incorporated on 14 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jagbir Pharmaceuticals by revenue are Ramsey Pharma Pvt Ltd, Strimed Pharmaceuticals Private Limited, 5G Care Pharma Private Limited, Sthree Pharmaceuticals Private Limited, KMRS Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Ankit Sharma was appointed as Director on 28 Jan 2026. Himanshu Gupta ceased to be Director on 31 Mar 2025. Ravi Malik was appointed as Director on 31 Mar 2025. Jagbir Pharmaceuticals has 5 board changes on record in total.
Yes, Jagbir Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-16-0011547).
The registered office of Jagbir Pharmaceuticals is at CO Sh. Vidya Sagar, Kharawar Rohtak, Haryana, India – 124021.
Jagbir Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages